Physician profile
Jared S Fredrickson
NPI 1902394893
$1,416.51
in general payments reported to CMS, 2019-2025
15 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $159 · 2023: $373 · 2024: $557 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234 · Entertainment: $23.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.58 |
| Entertainment | $23.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $299.35 | 2023-2025 | Miebo, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $269.31 | 2022-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Genentech USA, INC. | $140.31 | 2022-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Eylea Hd |
| Alcon Vision LLC | $115.11 | 2022-2025 | Clareon, Argos, Rocklatan |
| Sun Pharmaceutical Industries INC. | $111.11 | 2023-2025 | Cequa |
| Regeneron Pharmaceuticals, INC. | $98.82 | 2022 | |
| Amgen INC. | $75.18 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $57.13 | 2023-2024 | Tyrvaya |
| Astellas Pharma US INC | $29.51 | 2025 | Izervay |
| Optos, INC. | $23.78 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Horizon Therapeutics Plc | $22.03 | 2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $18.51 | 2023 | Syfovre |
| Sandoz INC. | $18.50 | 2024 | Cimerli |
| Abbvie INC. | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Fredrickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.